Literature DB >> 15270821

Investigation and endoscopic treatment for functional and anatomical obstruction of the nasolacrimal duct system.

P J Wormald1, A Tsirbas.   

Abstract

The purpose of this study was to assess the results of endonasal DCR in patients with a functional obstruction of the nasolacrimal system. The study design was a prospective non-randomized interventional case series. A prospective series of 102 consecutive endoscopic DCRs were evaluated with preoperative dacrycytography (DCG) and lacrimal scintillography. Evaluation of the DCG and scintillography allowed the patients to be classified as either having an anatomical or functional obstruction of the nasolacrimal system. The powered endoscopic DCR was performed between January 1999 and December 2001. Patients were followed up for a minimum of 12 months after surgery. In the 70 powered endoscopic DCRs for anatomical obstruction, 68 (97%) have remained asymptomatic with a free flow of fluorescein from the conjunctiva to the nose. In the patients who were classified as having a functional obstruction, 27 of 32 were asymptomatic (84%) with a free flow of fluorescein into the nose. To conclude, powered endoscopic DCR produces excellent results in patients with anatomical obstruction and good results in patients with functional obstruction of the nasolacrimal system.

Entities:  

Mesh:

Year:  2004        PMID: 15270821     DOI: 10.1111/j.1365-2273.2004.00836.x

Source DB:  PubMed          Journal:  Clin Otolaryngol Allied Sci        ISSN: 0307-7772


  11 in total

1.  Evaluation of Patients for Endoscopic DCR: Sac Syringing and Radionuclide Scintigraphy.

Authors:  Col Uma Patnaik; Maj Atul Gupta; Brig Ajith Nilakantan
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2018-05-16

2.  External and endoscopic dacryocystorhinostomy in chronic dacryocystitis: comparison of results.

Authors:  Ozgur Yigit; Mehmet Samancioglu; Umit Taskin; Serdar Ceylan; Kadir Eltutar; Murat Yener
Journal:  Eur Arch Otorhinolaryngol       Date:  2007-03-27       Impact factor: 2.503

3.  A clinical trial of endoscopic vs external dacryocystorhinostomy for partial nasolacrimal duct obstruction.

Authors:  F H Zaidi; S Symanski; J M Olver
Journal:  Eye (Lond)       Date:  2011-07-22       Impact factor: 3.775

4.  Endoscopic dacryocystorhinostomy with conventional instruments: results and advantages over external dacryocystorhinostomy.

Authors:  Vikas Sinha; Devang Gupta; Bela Prajapati; Yogesh More; Priyanka Khandelwal; Shashank Nath Singh; B Himanshu
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2008-10-22

5.  Surgical success rate comparison in functional nasolacrimal duct obstruction: simple lacrimal stent versus endoscopic versus external dacryocystorhinostomy.

Authors:  Won-Kyung Cho; Ji-Sun Paik; Suk-Woo Yang
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-05-08       Impact factor: 2.503

6.  Assessment and management of proximal and incomplete symptomatic obstruction of the lacrimal drainage system.

Authors:  Mohsen Bahmani Kashkouli; Farzad Pakdel; Victoria Kiavash
Journal:  Middle East Afr J Ophthalmol       Date:  2012-01

7.  Endoscopic dacryocystorhinostomy as treatment for lower lacrimal pathway obstructions in adults: Review article.

Authors:  Elina Penttilä; Grigori Smirnov; Henri Tuomilehto; Kai Kaarniranta; Juha Seppä
Journal:  Allergy Rhinol (Providence)       Date:  2015-01

8.  Outcomes of lacrimal gland injection of botulinum toxin in functional versus nonfunctional epiphora.

Authors:  Swati Singh; Akshay Gopinathan Nair; Md Shahid Alam; Bipasha Mukherjee
Journal:  Oman J Ophthalmol       Date:  2019 May-Aug

9.  A Comparison of Transcanalicular, Endonasal, and External Dacryocystorhinostomy in Functional Epiphora: A Minimum Two-Year Follow-Up Study.

Authors:  Can Ozturker; Bayasgalan Purevdorj; Gamze Ozturk Karabulut; Gamal Seif; Korhan Fazil; Yasser Anwar Khan; Pelin Kaynak
Journal:  J Ophthalmol       Date:  2022-03-23       Impact factor: 1.909

10.  Results of nonendoscopic endonasal dacryocystorhinostomy.

Authors:  Passorn Preechawai
Journal:  Clin Ophthalmol       Date:  2012-08-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.